oleanolic acid has been researched along with Parkinson Disease in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Basile, L; Copani, A; Giuffrida, ML; Guccione, S; Merlo, S; Sortino, MA | 1 |
Chang, CH; Liao, VH; Wei, CC | 1 |
Cao, W; Guo, Z; Han, B; Han, Z; Zhao, S | 1 |
3 other study(ies) available for oleanolic acid and Parkinson Disease
Article | Year |
---|---|
Identification of 5-Methoxyflavone as a Novel DNA Polymerase-Beta Inhibitor and Neuroprotective Agent against Beta-Amyloid Toxicity.
Topics: Alzheimer Disease; Cell Cycle; Cell Death; Cell Division; DNA Polymerase beta; DNA Replication; Enzyme Inhibitors; Flavones; Humans; Molecular Structure; Neurons; Neuroprotective Agents; Parkinson Disease | 2015 |
Anti-Parkinsonian effects of β-amyrin are regulated via LGG-1 involved autophagy pathway in Caenorhabditis elegans.
Topics: alpha-Synuclein; Animals; Animals, Genetically Modified; Antioxidants; Antiparkinson Agents; Autophagy; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Disease Models, Animal; Dopaminergic Neurons; Microtubule-Associated Proteins; Neurodegenerative Diseases; Oleanolic Acid; Oxidative Stress; Parkinson Disease | 2017 |
Protection against 1-methyl-4-phenyl pyridinium-induced neurotoxicity in human neuroblastoma SH-SY5Y cells by Soyasaponin I by the activation of the phosphoinositide 3-kinase/AKT/GSK3β pathway.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Apoptosis; Cell Line, Tumor; Disease Models, Animal; Glycogen Synthase Kinase 3 beta; Humans; Neuroprotective Agents; Oleanolic Acid; Parkinson Disease; Phosphatidylinositol 3-Kinase; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species; Saponins; Signal Transduction | 2016 |